dkNET community events and announcements in July, 2025

Dear dkNET Community,

dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.

dkNET News

• Thank you for visiting the NIDDK Data Science Corner at ADA 2025! dkNET was proud to host the NIDDK Data Science Corner at the ADA 2025 Scientific Sessions. Thank you to everyone who stopped by our booth and the participating program booths. It was a pleasure meeting so many scientists and hearing about your research and discuss what we can help! A big thank-you to all the NIDDK-funded data science and resource programs that participated in the NIDDK Data Science Corner. We’re grateful for your engagement and your contributions to advancing diabetes and metabolic disease research. If you weren’t able to visit in person, you can still explore the resources and participating programs online: https://dknet.org/data-science-corner

Events in July 2025

Jul. 02, 2025

Obesity Week 2025 Abstract Due

The preeminent international conference for obesity researchers and clinicians, ObesityWeek® is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy. Treating obesity requires multi-disciplinary approaches. This is the conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations. With more than 250 expert speakers presenting the latest research to best practices in clinical care, this conference has it all! ObesityWeek® 2025 will be held November 4-7 in Atlanta, Georgia.

Location:  Atlanta, GA, USA

More information: https://obesityweek.org/

Jul. 12-15, 2025

ENDO 2025

With over 7,000 attendees, nearly 2,500 abstracts and over 2 00 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.

Location:  San Francisco, CA, USA

More information: https://www.endocrine.org/meetings-and-events/endo-2025

Jul. 31, 2025

NIDDK Central Repository Webinar Series "Challenges, Opportunities, and Considerations for Researchers using Electronic Health Records and Real-World Data Sources"

This session is geared towards researchers interested in leveraging real-world data in biomedical and behavioral research, including:

• What is Real-World Data (RWD)
• Scientific value and quality considerations for collection, use, and sharing of RWD
• Using R WD as part of the scientific paradigm
• RWD resources

More information: https://repository.niddk.nih.gov/pages/webinars

 
Funding Opportunities Information and Deadlines in July 2025

Jul. 23, 2025

ADA Funding Opportunity Application Due: Pathway to Stop Diabetes® (2025) Award

To accelerate the research needed to stop this deadly disease, the American Diabetes Association’s bold transformational initiative, Pathway to Stop Diabetes®, is inspiring a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management, and cur es. We are building a human pathway to tackle the toughest questions in diabetes by driving research innovations through 1:1 mentorship and the creation of a brain trust in diabetes.

This call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease - and the pathway to this impact is clear. Our vision is to create a pathway to launch the next generation of trailblazers in diabetes research.

More information: https://professional.diabetes.org/research-g rants/current-funding-opportunities-pathway-stop-diabetes

Jul. 23, 2025

ADA Funding Opportunities Application Due: Postdoctoral Fellowship Award

The American Diabetes Association® (ADA) is committed to nurturing the next generation of leaders in diabetes research, which is why we are pleased to announce the application period of the Postdoctoral Fellowships Awards is now open! This award recognizes and supports outstanding researchers in their pursuit of innovative and impactful research projects. As there is a pressing need for more talented, early-stage investigators to jo in the field of diabetes research and tackle these challenges, postdoctoral training is an essential step in launching a successful research career and making significant contributions to the field. Our goal is to support exceptional training opportunities that will enable fellows to make significant advances in scientific research and contribute to the ADA's mission top revent and cure diabetes and to improve the lives of people affected by diabetes.

More information: https://pr ofessional.diabetes.org/research-grants/current-funding-opportunities/postdoctoral-fellowships

Jul. 30, 2025

Helmsley Funding Opportunity Full Proposal Due: T1D Innate Immunity Projects

The Helmsley T1D Program seeks to support studies that aim to evaluate or modulate the function of innate immune cells and pathways in T1D, with an emphasis on human disease during relatively early stages of disease (i.e., autoantibody positivity through early onset of clinical disease).

Of specific interest are research plans that include:

Analyzing the type and function of innate cells (e.g. macrophages, dendritic cells, natural killer cells) present in the pancreas and their interactions with other cells, tissue-resident or otherwise;

• Investigating mechanisms of T1D pathogenesis that involves innate immunity;
• Identifying or validating biomarkers of disease progression or response to treatment based on innate immune cells;
• Identifying or validating therapeutic innate immune cell targets; and
• Developing or validating preclinical or clinical therapies to prevent or delay T1D that target or use innate immune cell pathways.

Proposed activities can include, but are not limited to:

• Generation or testing of hypotheses using human samples;
• Profiling or functional analysis of innate immune cells in pancreas samples and pancreas slices;
• Analysis of preexisting relevant data sets, either publicly available or generated by the applicant; and
• Preclinical or clinical activities that advance or build evidence for a specific therapeutic concept based on existing know ledge of the role of innate immunity in T1D.

Like other fields, scientific research in T1D has been challenged by limited access to human samples. To facilitate potentially impactful studies, Helmsley has partnered with two leading T1D networks, the Network for Pancreatic Organ donors with Diabetes (nPOD) and INNODIA to enable access to disease relevant samples and connected clinical and biological data in relation to this RFP. Applicants who proceed to the full proposal stage with a project that includes access to nPOD or INN ODIA samples will work with the relevant network team to hone final research plans and access to samples. Concept Notes Due Date: April 30, 2025.  Full Proposal Due Date: July 30, 2025.

More information: https://helmsleytrust.org/request_for_proposal/innate-immunity-t1d-rfp/